JP2023501111A5 - - Google Patents
Info
- Publication number
- JP2023501111A5 JP2023501111A5 JP2022523315A JP2022523315A JP2023501111A5 JP 2023501111 A5 JP2023501111 A5 JP 2023501111A5 JP 2022523315 A JP2022523315 A JP 2022523315A JP 2022523315 A JP2022523315 A JP 2022523315A JP 2023501111 A5 JP2023501111 A5 JP 2023501111A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201901337 | 2019-11-14 | ||
| DKPA201901337 | 2019-11-14 | ||
| PCT/IB2020/060692 WO2021094993A1 (en) | 2019-11-14 | 2020-11-13 | Synthetic composition for balancing the bile acid profile in the intestine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023501111A JP2023501111A (ja) | 2023-01-18 |
| JP2023501111A5 true JP2023501111A5 (https=) | 2023-11-07 |
| JPWO2021094993A5 JPWO2021094993A5 (https=) | 2023-11-07 |
Family
ID=75912919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523315A Withdrawn JP2023501111A (ja) | 2019-11-14 | 2020-11-13 | 腸管における胆汁酸プロファイルを均衡させるための合成組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220378809A1 (https=) |
| EP (1) | EP4058031A4 (https=) |
| JP (1) | JP2023501111A (https=) |
| KR (1) | KR20220101131A (https=) |
| CN (1) | CN114728015A (https=) |
| BR (1) | BR112022009214A2 (https=) |
| CA (1) | CA3160629A1 (https=) |
| WO (1) | WO2021094993A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201903823QA (en) | 2014-10-31 | 2019-05-30 | Whole Biome Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| CN111372596A (zh) | 2017-08-30 | 2020-07-03 | 潘德勒姆治疗公司 | 用于治疗微生物组相关病症的方法和组合物 |
| CA3106315A1 (en) | 2018-07-19 | 2020-01-23 | Pendulum Therapeutics, Inc. | Methods and compositions for microbial engraftment |
| TW202126317A (zh) | 2019-09-24 | 2021-07-16 | 美商普拉塔生技公司 | 用於治療發炎和免疫疾病之組成物和方法 |
| WO2022026415A1 (en) * | 2020-07-31 | 2022-02-03 | Abbott Laboratories | Method of preventing, reducing or delaying fatty liver disease |
| WO2022271729A1 (en) * | 2021-06-21 | 2022-12-29 | Pendulum Therapeutics, Inc. | Compositions comprising microbes and methods of use and making thereof |
| CN115948273B (zh) * | 2022-06-21 | 2023-07-18 | 合肥瀚微生物科技有限公司 | 治疗糖尿病及相关病症的两歧双歧杆菌 |
| WO2024126578A1 (en) * | 2022-12-13 | 2024-06-20 | Dsm Ip Assets B.V. | Synthetic composition comprising a human milk oligosaccharide for microbiota modulation |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2735108B1 (en) * | 2011-07-22 | 2016-12-21 | Telefonaktiebolaget LM Ericsson (publ) | Radio base station, radio network node and methods therein for detecting a faulty antenna |
| AT515152B1 (de) * | 2013-11-26 | 2015-12-15 | Chemiefaser Lenzing Ag | Verfahren zum Vorbehandeln von rückgewonnenen Baumwollfasern zur Verwendung bei der Herstellung von Formkörpern aus regenerierter Cellulose |
| EP3212197A4 (en) * | 2014-10-29 | 2018-07-11 | Glycom A/S | Synthetic composition and method for treating irritable bowel syndrome |
| US11040049B2 (en) * | 2014-10-29 | 2021-06-22 | Glycom A/S | Composition comprising HMSs/HMOs and use thereof |
| US10987368B2 (en) * | 2014-12-08 | 2021-04-27 | Glycom A/S | Synthetic composition for preventing or treating CVD |
| US10751354B2 (en) * | 2015-09-14 | 2020-08-25 | Glycom A/S | Synthetic composition for microbiota modulation |
| CN108348536B (zh) * | 2015-11-17 | 2021-09-24 | 格礼卡姆股份公司 | 治疗抗生素相关性并发症的合成组合物 |
| WO2017215721A1 (en) * | 2016-06-15 | 2017-12-21 | Glycom A/S | Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders |
| US11278558B2 (en) * | 2017-03-01 | 2022-03-22 | Glycom A/S | Synthetic composition for microbiota modulation |
| AU2018250337B2 (en) * | 2017-04-07 | 2024-02-15 | Children's Hospital Medical Center | Treatment of inflammatory bowel diseases with 2'-fucosyllactose compounds |
| CN111587376A (zh) * | 2017-09-13 | 2020-08-25 | 进化生物系统股份有限公司 | 哺乳动物婴儿的代谢组学修正 |
| BR112020010843A2 (pt) * | 2017-11-30 | 2020-11-10 | Glycom A/S | oligossacarídeos do leite humano e composições sintéticas desses para modulação da microbiota |
-
2020
- 2020-11-13 EP EP20888545.9A patent/EP4058031A4/en not_active Withdrawn
- 2020-11-13 KR KR1020227019613A patent/KR20220101131A/ko not_active Withdrawn
- 2020-11-13 WO PCT/IB2020/060692 patent/WO2021094993A1/en not_active Ceased
- 2020-11-13 JP JP2022523315A patent/JP2023501111A/ja not_active Withdrawn
- 2020-11-13 US US17/755,956 patent/US20220378809A1/en not_active Abandoned
- 2020-11-13 CA CA3160629A patent/CA3160629A1/en active Pending
- 2020-11-13 CN CN202080078561.7A patent/CN114728015A/zh active Pending
- 2020-11-13 BR BR112022009214A patent/BR112022009214A2/pt not_active IP Right Cessation